Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 12:59 AM
Ignite Modification Date: 2025-12-25 @ 11:12 PM
NCT ID: NCT00715793
Description: None
Frequency Threshold: 5
Time Frame: None
Study: NCT00715793
Study Brief: Combination of Decitabine and Temozolomide in the Treatment of Patients With Metastatic Melanoma
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
DAC (Decitabine) + TMZ (Temozolomide) Comprehensive listing of adverse events are presented in total (includes events from both Phase 1 and and Phase 2 of study). None None 7 39 39 39 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Dyspnea (shortness of breath) SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders None View
Febrile neutropenia SYSTEMATIC_ASSESSMENT Infections and infestations None View
Hypoxia SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders None View
Neuropathy: motor SYSTEMATIC_ASSESSMENT Nervous system disorders None View
Pain, Abdomen NOS SYSTEMATIC_ASSESSMENT General disorders None View
Pain, Back SYSTEMATIC_ASSESSMENT General disorders None View
Peripheral arterial ischemia SYSTEMATIC_ASSESSMENT Vascular disorders None View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Albumin, serum-low (hypoalbuminemia) SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders None View
Allergic rhinitis (including sneezing, nasal stuffiness, postnasal drip) SYSTEMATIC_ASSESSMENT Immune system disorders None View
Anorexia SYSTEMATIC_ASSESSMENT General disorders None View
Confusion SYSTEMATIC_ASSESSMENT Nervous system disorders None View
Constipation SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View
Cough SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders None View
Diarrhea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View
Dizziness SYSTEMATIC_ASSESSMENT Nervous system disorders None View
Dyspnea (shortness of breath) SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders None View
Edema: limb SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders None View
Fatigue (asthenia, lethargy, malaise) SYSTEMATIC_ASSESSMENT General disorders None View
Fever (in the absence of neutropenia, where neutropenia is defined as ANC <1.0 x 10e9/L) SYSTEMATIC_ASSESSMENT General disorders None View
Heartburn/dyspepsia SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View
Hemoglobin SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders None View
Hemorrhage/Bleeding - Other (Specify, __) SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders None View
Hypertension SYSTEMATIC_ASSESSMENT Cardiac disorders None View
Infection with normal ANC or Grade 1 or 2 neutrophils, Skin (cellulitis) SYSTEMATIC_ASSESSMENT Infections and infestations None View
Infection with normal ANC or Grade 1 or 2 neutrophils, Upper airway NOS SYSTEMATIC_ASSESSMENT Infections and infestations None View
Insomnia SYSTEMATIC_ASSESSMENT General disorders None View
Leukocytes (total WBC) SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders None View
Metabolic/Laboratory - Other (Specify, __) SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders None View
Mood alteration, Anxiety SYSTEMATIC_ASSESSMENT Nervous system disorders None View
Mood alteration, Depression SYSTEMATIC_ASSESSMENT Nervous system disorders None View
Mucositis/stomatitis (clinical exam), Oral cavity SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View
Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View
Neuropathy: sensory SYSTEMATIC_ASSESSMENT Nervous system disorders None View
Neutrophils/granulocytes (ANC/AGC) SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders None View
Pain, Abdomen NOS SYSTEMATIC_ASSESSMENT General disorders None View
Pain, Back SYSTEMATIC_ASSESSMENT General disorders None View
Pain, Chest wall SYSTEMATIC_ASSESSMENT General disorders None View
Pain, Extremity-limb SYSTEMATIC_ASSESSMENT General disorders None View
Pain, Head/headache SYSTEMATIC_ASSESSMENT General disorders None View
Pain, Joint SYSTEMATIC_ASSESSMENT General disorders None View
Phosphate, serum-low (hypophosphatemia) SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders None View
Platelets SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders None View
Pruritus/itching SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View
Rash/desquamation SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View
Taste alteration (dysgeusia) SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View
Vomiting SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View
Weight loss SYSTEMATIC_ASSESSMENT General disorders None View